scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.89.1.151 |
P698 | PubMed publication ID | 8281642 |
P2093 | author name string | Feruglio GA | |
Rocco M | |||
Beltrami CA | |||
Anversa P | |||
Sonnenblick EH | |||
Olivetti G | |||
Puricelli C | |||
Cigola E | |||
Quaini F | |||
Finato N | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ischemic cardiomyopathy | Q12075432 |
P304 | page(s) | 151-163 | |
P577 | publication date | 1994-01-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Structural basis of end-stage failure in ischemic cardiomyopathy in humans | |
P478 | volume | 89 |
Q51725730 | A Multidisciplinary Assessment of Remote Myocardial Fibrosis After Reperfused Myocardial Infarction in Swine and Patients. |
Q51817202 | A mathematical model to evaluate control strategies for mechanical circulatory support. |
Q77933851 | A novel biochemical approach to congestive heart failure: cardiac troponin T |
Q73597772 | Abnormalities of cardiocytes in regions bordering fibrous scars of dogs with heart failure |
Q64084663 | Acellular Extracellular Matrix Bioscaffolds for Cardiac Repair and Regeneration |
Q35047817 | Activation of endoplasmic reticulum stress response during the development of ischemic heart disease |
Q34459268 | Adaptive registration of varying contrast-weighted images for improved tissue characterization (ARCTIC): application to T1 mapping |
Q37190311 | Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts |
Q38733754 | Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease. |
Q36252910 | Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance |
Q64264854 | Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon? |
Q38596695 | Aging Effects on Cardiac Progenitor Cell Physiology |
Q35155965 | Aging and Cardiac Fibrosis. |
Q44142573 | An ovine model of postinfarction dilated cardiomyopathy |
Q34490923 | Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes |
Q30846548 | Apoptosis in dilated cardiomyopathy |
Q73352327 | Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device |
Q93089068 | Application of Bioengineered Materials in the Surgical Management of Heart Failure |
Q52656822 | Assessment of Remote Myocardium Heterogeneity in Patients with Ventricular Tachycardia Using Texture Analysis of Late Iodine Enhancement (LIE) Cardiac Computed Tomography (cCT) Images. |
Q36298226 | Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality |
Q79337302 | Atrophic degeneration and loss of myocytes of residual left ventricular myocardium after Dor operation for ischemic cardiomyopathy associated with left ventricular remodeling |
Q43509334 | Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polyamine synthesis |
Q38447384 | Automated scar quantification by CMR: a step in the right direction. |
Q90223979 | Autophagy and Inflammasome Activation in Dilated Cardiomyopathy |
Q73925072 | Backscattered electron imaging: A new method for the study of cardiomyocyte architecture using scanning electron microscopy |
Q35571962 | Biomaterial strategies for alleviation of myocardial infarction |
Q90593191 | CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema |
Q53823555 | Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells. |
Q38984959 | Can Adiponectin Help us to Target Diastolic Dysfunction? |
Q52936783 | Cardiac MRI Anatomy and Function as a Substrate for Arrhythmias. |
Q34200316 | Cardiac Regeneration using Human Embryonic Stem Cells: Producing Cells for Future Therapy |
Q24615347 | Cardiac applications for human pluripotent stem cells |
Q41899486 | Cardiac remodelling |
Q37294677 | Cardiac shock wave therapy: assessment of safety and new insights into mechanisms of tissue regeneration |
Q36267790 | Cardiac stem cells and mechanisms of myocardial regeneration |
Q37206379 | Cardiac stem cells and myocardial disease |
Q83150650 | Cardiac tissue engineering |
Q31148531 | Cardiomyocyte regeneration from circulating bone marrow cells in mice |
Q46740748 | Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization |
Q38072123 | Caspase-3 as a therapeutic target for heart failure. |
Q36903477 | Caspases in myocardial infarction. |
Q35138063 | Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited |
Q77802850 | Cell cycle control in the terminally differentiated myocyte. A platform for myocardial repair? |
Q34061092 | Cellular and molecular pathways to myocardial necrosis and replacement fibrosis |
Q34432633 | Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation |
Q37502208 | Chemokines and cardiac fibrosis. |
Q44559048 | Chronic coronary artery stenosis induces impaired function of remote myocardium: MRI and spectroscopy study in rat. |
Q35581752 | Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure |
Q44485638 | Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium |
Q33713690 | Clinical insights on the use of highly sensitive cardiac troponin assays |
Q74180241 | Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling |
Q36054295 | Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium |
Q90627860 | Computational Model Predicts Paracrine and Intracellular Drivers of Fibroblast Phenotype After Myocardial Infarction |
Q36662036 | Concise review: stem cells, myocardial regeneration, and methodological artifacts |
Q42425309 | Congestive heart failure: where homeostasis begets dyshomeostasis |
Q34032407 | Connective tissue and the heart. Functional significance and regulatory mechanisms |
Q35774278 | Contemporary perspective on endogenous myocardial regeneration |
Q77298825 | Coronary artery constriction in rats: necrotic and apoptotic myocyte death |
Q35005455 | Development of a xeno-free autologous culture system for endothelial progenitor cells derived from human umbilical cord blood |
Q73008868 | Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure |
Q43544082 | Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin |
Q36114162 | Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones |
Q52566595 | Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart. |
Q30375302 | EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. |
Q55638585 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. |
Q45939560 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. |
Q54638672 | Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure. |
Q51847409 | Early maternal separation has mild effects on cardiac autonomic balance and heart structure in adult male rats. |
Q40991721 | Effect of nitrates on myocardial remodeling after acute myocardial infarction |
Q33223037 | Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction |
Q46916947 | Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts |
Q34578568 | Electrical and structural remodeling of the failing ventricle |
Q37394544 | Evaluating the hemodynamical response of a cardiovascular system under support of a continuous flow left ventricular assist device via numerical modeling and simulations |
Q77947869 | Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats |
Q81606863 | Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies |
Q35955262 | Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology |
Q92309133 | Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure |
Q38057701 | Fibrosis and heart failure |
Q35660795 | Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system |
Q34869712 | G protein-coupled receptor kinase-2 is a novel regulator of collagen synthesis in adult human cardiac fibroblasts |
Q52563144 | Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor. |
Q34525560 | Global intracoronary infusion of allogeneic cardiosphere-derived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium |
Q33738009 | Growth hormone therapy for heart failure: swimming against the stream |
Q49917885 | Guidelines for Experimental Models of Myocardial Ischemia and Infarction |
Q37994258 | HIF-prolyl hydroxylases and cardiovascular diseases |
Q73853044 | Histological remodeling in an ovine heart failure model resembles human ischemic cardiomyopathy |
Q47608058 | Histopathologic Assessment of Myocardial Regeneration |
Q78594584 | Histopathologic time course of myocardial infarct in rabbit hearts |
Q37878952 | Identification of a coronary stem cell in the human heart |
Q44856581 | Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy |
Q53980136 | Increased expression of cardiotrophin-1 during ventricular remodeling in hypertensive rats. |
Q21284499 | Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression |
Q37293114 | Inhibition of osteopontin reduce the cardiac myofibrosis in dilated cardiomyopathy via focal adhesion kinase mediated signaling pathway |
Q38631821 | Integrins and integrin-related proteins in cardiac fibrosis |
Q35500640 | Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway. |
Q38161896 | Investigational drugs targeting cardiac fibrosis |
Q73622517 | Is apoptosis present in progression to chronic hypertensive heart failure? |
Q43917350 | Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium |
Q40528523 | Ischemic cardiomyopathy: myocyte cell loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia |
Q61455288 | Left Ventricular Remodelling in Post-myocardial Infarction Patients with Left Ventricular Ejection Fraction 40-50% vs 25-39%. Influence of Nisoldipine Treatment?: An Echocardiographic Substudy from the DEFIANT II Study |
Q45764505 | Left ventricular morphology of the giraffe heart examined by stereological methods |
Q44054779 | Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure |
Q33557290 | MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium |
Q37090568 | Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium |
Q26824231 | Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies |
Q35102230 | Mapping genetic contributions to cardiac pathology induced by Beta-adrenergic stimulation in mice |
Q34340393 | Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications |
Q46639330 | Mechanism of sudden cardiac death in pigs with viable chronically dysfunctional myocardium and ischemic cardiomyopathy |
Q93099741 | Mechanisms of cardiac collagen deposition in experimental models and human disease |
Q36699897 | Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure |
Q35490630 | Melatonin protects against myocardial hypertrophy induced by lipopolysaccharide |
Q37296154 | Metabolic modulation and cellular therapy of cardiac dysfunction and failure |
Q36597950 | Mineralocorticoid receptor antagonism confers cardioprotection in heart failure |
Q36477618 | Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease |
Q37983499 | Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states |
Q28389063 | Mitochondrial dysfunction in cardiac aging |
Q42803419 | Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol |
Q31002195 | Mobilized bone marrow cells repair the infarcted heart, improving function and survival |
Q28116119 | Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction |
Q30274835 | Multiparametric CMR imaging of infarct remodeling in a percutaneous reperfused Yucatan mini-pig model |
Q36836362 | Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage |
Q37371632 | Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. |
Q26996570 | Myocardial Tissue Characterization: Histological and Pathophysiological Correlation |
Q44008848 | Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol. |
Q37623441 | Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. |
Q34686973 | Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus |
Q38632039 | Myocardial infarction: stem cell transplantation for cardiac regeneration. |
Q54943621 | Myocardial native T1 and extracellular volume with healthy ageing and gender. |
Q37926160 | Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease |
Q33853869 | Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure |
Q37641749 | Myocardial remodeling after infarction: the role of myofibroblasts |
Q73711201 | Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent |
Q36221185 | Myocyte proliferation in end-stage cardiac failure in humans |
Q37357150 | Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation |
Q38294134 | Myofibroblast secretome and its auto-/paracrine signaling |
Q38064729 | Myofibroblast-mediated mechanisms of pathological remodelling of the heart |
Q41391367 | Myofibroblasts and local angiotensin II in rat cardiac tissue repair |
Q37972978 | Myofibroblasts in the infarct area: concepts and challenges |
Q50916534 | Native T1 value in the remote myocardium is independently associated with left ventricular dysfunction in patients with prior myocardial infarction. |
Q77111607 | Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling |
Q34664054 | Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts |
Q37373506 | Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy |
Q35146909 | Pathogenetic basis of myocardial dysfunction and amenability to reversal |
Q41733651 | Pathological versus physiological left ventricular hypertrophy: a review |
Q40581661 | Pathophysiologic aspects of end-stage heart failure |
Q34972837 | Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. |
Q34239875 | Pathophysiology of chronic heart failure |
Q54500659 | Patient profile modulates cardiac c-kit(+) progenitor cell availability and amplification potential. |
Q34357219 | Pericytes at the intersection between tissue regeneration and pathology |
Q80539477 | Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion |
Q41715319 | Prevention of ventricular remodeling |
Q40296183 | Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure |
Q28084341 | Quality control systems in cardiac aging |
Q37264534 | Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure |
Q57621915 | Recent Developments in Imaging of Myocardial Angiotensin Receptors |
Q48831553 | Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. |
Q37638903 | Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy |
Q39221569 | Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease |
Q91581869 | Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by β-arrestins |
Q73476733 | Remodeling after myocardial infarction in humans is not associated with interstitial fibrosis of noninfarcted myocardium |
Q37116380 | Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial Infarction |
Q37104058 | Repairing damaged myocardium: evaluating cells used for cardiac regeneration |
Q36176076 | Reverse remodeling and recovery from cachexia in rats with aldosteronism |
Q36203123 | Role of apoptosis in ventricular remodeling |
Q49526018 | Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease |
Q35820877 | Sarcomere alignment is regulated by myocyte shape |
Q46745968 | Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix |
Q36597800 | Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease |
Q37005901 | Sex-related differences in intrinsic myocardial properties influence cardiac function in middle-aged rats during infarction-induced left ventricular remodeling |
Q41906276 | Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery |
Q37544884 | Stem cell therapy for cardiac repair: benefits and barriers |
Q38046544 | Stem cell transplantation as a therapy for cardiac fibrosis. |
Q37261623 | Stem cells for heart cell therapies |
Q37708148 | Stem cells for heart failure in the aging heart |
Q37977013 | Structural remodeling and mechanical function in heart failure |
Q37717191 | Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification |
Q42790907 | T1 Mapping for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure. |
Q36417705 | T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. |
Q38190880 | T1 mapping in ischaemic heart disease |
Q37352324 | TRPM7 is down-regulated in both left atria and left ventricle of ischaemic cardiomyopathy patients and highly related to changes in ventricular function. |
Q34873016 | Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1. |
Q36642702 | Targeting angiogenesis versus myogenesis with cardiac cell therapy |
Q37924999 | Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β. |
Q34892110 | Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure |
Q46825442 | Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation |
Q43096198 | Technology platform development for targeted plasma metabolites in human heart failure |
Q60950146 | Temporal Frame of Immune Cell Infiltration during Heart Failure Establishment: Lessons from Animal Models |
Q34086876 | Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload |
Q33656014 | Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism |
Q38177694 | The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction |
Q64069385 | The assessment of pressure-volume relationship during exercise stress echocardiography predicts left ventricular remodeling and eccentric hypertrophy in patients with chronic heart failure |
Q37579947 | The cardioprotective efficacy of TVP1022 against ischemia/reperfusion injury and cardiac remodeling in rats |
Q42252887 | The human heart: a self-renewing organ |
Q38033889 | The need for standardized protocols for future clinical trials of cell therapy |
Q37161329 | The pathogenesis of cardiac fibrosis. |
Q74660329 | The pathophysiology of advanced heart failure |
Q30502828 | The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion. |
Q42095427 | The role of Ca2+/calmodulin-dependent protein kinase II and calcineurin in TNF-α-induced myocardial hypertrophy |
Q34061245 | The role of inflammatory and fibrogenic pathways in heart failure associated with aging. |
Q41117393 | Three-dimension structure of ventricular myocardial fibers after myocardial infarction |
Q55128147 | Three-dimensional Cardiomyocytes Structure Revealed By Diffusion Tensor Imaging and Its Validation Using a Tissue-Clearing Technique. |
Q79899495 | Thymoglobulin administered early after heart transplantation reduces early myocardial hypertrophy assessed by morphometric studies |
Q38322176 | Tissue engineering approaches to heart repair |
Q28585906 | Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice |
Q36915712 | Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. |
Q46661981 | Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta |
Q55322363 | Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. |
Q24625500 | Transient receptor potential (TRP) channels and cardiac fibrosis |
Q40026105 | Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism |
Q37298352 | Wall thickness of coronary vessels varies transmurally in the LV but not the RV: implications for local stress distribution |
Q47097309 | Zebrafish Larvae Model of Dilated Cardiomyopathy Induced by Terfenadine |
Q73074717 | [Plasticity of the myocardium in pediatric cardiology] |
Q34603394 | β-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling |
Search more.